Brief: Tracon Pharmaceuticals Announces Up To $30 Mln Financing Related To Arbitration Award Decision Expected In Q1 2023
27/12/2022 13:15
Dec 27 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS ANNOUNCES UP TO $30M NON-RECOURSE
NON-DILUTIVE FINANCING RELATED TO ARBITRATION AWARD DECISION
EXPECTED IN Q1 2023
Source text for Eikon: ID:nGNXbMJWqJ
Further company coverage: TCON.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants